AN OPEN-LABEL, 6-MONTH OBSERVATIONAL STUDY OF PATIENTS WITH SCHIZOPHRENIA OR SCHIZOAFFECTIVE DISORDERS RECEIVING RISPERIDONE LONG ACTING INJECTION

被引：0
|
作者：
Hustig, Harry [1 ]
Newton, Richard [2 ]
Nyst, Phil [3 ]
机构：
[1] Glenside Hosp, Eastwood, SA, Australia
[2] Frankston Hosp, Frankston, Vic, Australia
[3] Royal Brisbane & Womens Hosp, Brisbane, Qld, Australia
来源：
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY | 2009年 / 43卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：A56 / A56
页数：1
相关论文
共 50 条
  • [41] Aripiprazole for Patients with Schizophrenia and Schizoaffective Disorder: An Open-Label, Randomized, Study Versus Haloperidol
    de Oliveira, Irismar Reis
    Elkis, Helio
    Gattaz, Wagner Farid
    Chaves, Ana Cristina
    de Sena, Eduardo Ponde
    de Matos e Souza, Fabio Gomes
    Campos, Joao Alberto
    Bueno, Joao Romildo
    Costa e Silva, Jorge Alberto
    Louza, Mario Rodrigues
    de Abreu, Paulo Belmonte
    CNS SPECTRUMS, 2009, 14 (02) : 93 - 102
  • [42] A comparative randomized, open-label, rater-blinded study of paliperidone palmitate and risperidone long-acting injectable therapy in patients with schizophrenia
    Li, H.
    Rui, Q.
    Ning, X.
    Xu, H.
    Gu, N.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 167 - 167
  • [43] Early clinical experience with risperidone long-acting injection: A prospective, 6-month follow-up of 100 patients
    Taylor, DM
    Young, CL
    Mace, S
    Patel, MX
    JOURNAL OF CLINICAL PSYCHIATRY, 2004, 65 (08) : 1076 - 1083
  • [44] Risperidone long acting injection: an 18 month retrospective study
    Deslandes, PN
    Thomas, A
    Faulconbridge, GM
    Davies, WC
    JOURNAL OF PSYCHOPHARMACOLOGY, 2004, 18 (03) : A65 - A65
  • [45] Role of risperidone in bipolar II:: an open 6-month study
    Vieta, E
    Gastó, C
    Colom, F
    Reinares, M
    Martínez-Arán, A
    Banabarre, A
    Akiskal, HS
    JOURNAL OF AFFECTIVE DISORDERS, 2001, 67 (1-3) : 213 - 219
  • [46] MIRROR IMAGE STUDIES OF RISPERIDONE LONG-ACTING INJECTION FOR CHRONIC SCHIZOPHRENIA AND SCHIZOAFFECTIVE DISORDER
    Einarson, T. R.
    Jensen, R.
    Hemels, M.
    VALUE IN HEALTH, 2012, 15 (07) : A334 - A334
  • [47] SAFETY OF SUBCUTANEOUS BELIMUMAB IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: A 6-MONTH OPEN-LABEL EXTENSION STUDY
    Doria, A.
    Stohl, W.
    Schwarting, A.
    Scheinberg, M.
    Hammer, A.
    Kleoudis, C.
    Groark, J.
    Fox, N. L.
    Roth, D.
    Bass, D.
    Gordon, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 861 - 861
  • [48] A 6-MONTH OPEN-LABEL EXTENSION STUDY OF THE SAFETY AND EFFICACY OF INTRAVENOUS BELIMUMAB IN PATIENTS WITH LUPUS NEPHRITIS
    Furie, R.
    Rovin, B. H.
    Houssiau, F.
    Contreras, G.
    Curtis, P.
    Madan, A.
    Jones-Leone, A.
    Okily, M.
    Roth, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 591 - 592
  • [49] Study of the efficacy and safety of risperidone long acting injection in elderly schizophrenia patients
    Inoue, Y.
    Suzuki, H.
    Ootomo, M.
    Takeda, S.
    Kawaguchi, Y.
    Gen, K.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010, 20 : S438 - S438
  • [50] Rivastigmine Patch Ameliorates Depression in Mild AD: Preliminary Evidence From a 6-Month Open-label Observational Study
    Spalletta, Gianfranco
    Gianni, Walter
    Giubilei, Franco
    Casini, Anna R.
    Sancesario, Giuseppe
    Caltagirone, Carlo
    Cravello, Luca
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2013, 27 (03): : 289 - 291
12345